Citation Impact
1 by Nobel laureates 1 from Science/Nature 58 standout
Citing Papers
Covalent targeted radioligands potentiate radionuclide therapy
2024 StandoutNature
[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study
2024 Standout
Works of Patrick Butler being referenced
Australasian Gastrointestinal Trials Group (AGITG) CONTROL NET Study: Phase II study evaluating the activity of 177Lu-Octreotate peptide receptor radionuclide therapy (LuTate PRRT) and capecitabine, temozolomide CAPTEM)—First results for pancreas and updated midgut neuroendocrine tumors (pNETS, mNETS).
2020
Author Peers
| Author | SM | PSIR | Marketing | SPS | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|---|
| Patrick Butler | 187 | 94 | 243 | 270 | 39 | 1.0k | |
| Murali Balaji | 13 | 20 | 20 | 121 | 16 | 245 | |
| K.-S. Li | 2 | 105 | |||||
| Michal Ramon | 1 | 15 | 681 | ||||
| Oh-Jin Kwon | 141 | 5 | 13 | 21 | 21 | 488 | |
| Bülent Selek | 5 | 11 | 274 |
All Works
Loading papers...